Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H5HP
|
||||
Former ID |
DNC010364
|
||||
Drug Name |
1-amino-4-chloroanthracene-9,10-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C14H8ClNO2
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)Cl)N
|
||||
InChI |
1S/C14H8ClNO2/c15-9-5-6-10(16)12-11(9)13(17)7-3-1-2-4-8(7)14(12)18/h1-6H,16H2
|
||||
InChIKey |
AWACQBFBMROGQC-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2a receptor | Target Info | Inhibitor | [1] | |
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Parkinson's disease | |||||
Alcoholism | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
PathWhiz Pathway | Intracellular Signalling Through Adenosine Receptor A2a and Adenosine | ||||
Reactome | NGF-independant TRKA activation | ||||
Adenosine P1 receptors | |||||
G alpha (s) signalling events | |||||
Surfactant metabolism | |||||
WikiPathways | Nucleotide GPCRs | ||||
Monoamine Transport | |||||
GPCRs, Class A Rhodopsin-like | |||||
NGF signalling via TRKA from the plasma membrane | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References | |||||
REF 1 | J Med Chem. 2010 Feb 25;53(4):1799-809.Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.